Utility Study in Diffuse Large B-Cell Lymphoma (DLBCL)
- Cancer
- Non Hodgkin Lymphoma (NHL)
- Diffuse Large B-Cell Lymphoma (DLBCL)
Completed
- United Kingdom
NCT02708732 ML29956
Trial Summary
This study is a prospective, cross-sectional survey to be administered to real patients in remission from DLBCL using a 15-minute postal or online survey. The project is designed to describe the impact of DLBCL remission on health utility and quality of life. Data collection will occur over a 4-month period.
UK Utility Study in Diffuse Large B-Cell Lymphoma
Eligibility Criteria
- Adults greater than or equal to (>/=) 18 years of age
- Diagnosis of DLBCL and currently in first remission
- Prior drug treatment for DLBCL
- Receiving active treatment for DLBCL
- Relapsed following any treatment for DLBCL
For the latest version of this information please go to www.forpatients.roche.com